San Diego, CA – Eclipsebio has announced the acquisition of Terrain Bio (https://www.terrain.bio/). According to the company announcement, Eclipsebio is a private biotechnology company headquartered in San Diego developing first-in-class technologies, analytics, and platforms for the development of tomorrows RNA-based and RNA-targeting therapies. With the companys extensive experience in supporting early-stage basic research through to evaluating preclinical therapies, Eclipsebio provides unparalleled support for obtaining deep insights into RNA and therapeutic biology. The company offers its solutions as end-to-end partnerships for biopharma and project-based services for academics.

To learn more about Eclipsebio, visit https://eclipsebio.com/
Company LinkedIn Page: https://www.linkedin.com/company/eclipse-bioinnovations/

Company Contact:

Eclipsebio
5770 Oberlin Dr.
San Diego, CA 92121
855-727-2547

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.